FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
发生了什么
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
摘要按规则整理自下方来源原文